25iP-NBOMe
25iP-NBOMe[edit | edit source]
25iP-NBOMe is a synthetic psychedelic compound belonging to the NBOMe class. It is a derivative of the phenethylamine 2C-iP and is known for its potent hallucinogenic effects. The compound is part of a larger group of substances that have been explored for their psychoactive properties.
Chemical Structure and Properties[edit | edit source]
25iP-NBOMe is chemically related to other NBOMe compounds, such as 25I-NBOMe and 25C-NBOMe. The structure of 25iP-NBOMe includes a methoxybenzyl group attached to the nitrogen of the phenethylamine backbone, which is characteristic of the NBOMe series. This modification significantly increases the compound's affinity for the 5-HT2A receptor, which is primarily responsible for its psychedelic effects.
Pharmacology[edit | edit source]
The primary mechanism of action for 25iP-NBOMe is its agonism of the 5-HT2A receptor, a subtype of the serotonin receptor. This interaction is believed to be responsible for the hallucinogenic effects experienced by users. The compound may also interact with other serotonin receptor subtypes, contributing to its overall pharmacological profile.
Effects[edit | edit source]
Users of 25iP-NBOMe report a range of effects, including visual and auditory hallucinations, altered perception of time, and changes in mood and cognition. The intensity and duration of these effects can vary depending on the dose and individual sensitivity. As with other NBOMe compounds, there is a risk of adverse effects, particularly at higher doses.
Safety and Legal Status[edit | edit source]
The safety profile of 25iP-NBOMe is not well-established, and there have been reports of severe adverse reactions, including vasoconstriction, tachycardia, and seizures. Due to these risks, the compound is often classified as a research chemical and is not approved for human consumption in many jurisdictions. The legal status of 25iP-NBOMe varies by country, with some places having specific bans on NBOMe compounds.
Related Compounds[edit | edit source]
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
